title: The dark side of extracellular ATP in kidney diseases.
abstract: Intracellular ATP is the most vital source of cellular energy for biologic systems, whereas extracellular ATP is a multifaceted mediator of several cell functions via its interaction, in an autocrine or paracrine manner, with P2 purinergic receptors expressed on the cell surface. These ionotropic and metabotropic P2 purinergic receptors modulate a variety of physiologic events upon the maintenance of a highly sensitive "set point," the derangement of which may lead to the development of key pathogenic mechanisms during acute and chronic diseases. Growing evidence suggests that extracellular ATP signaling via P2 purinergic receptors may be involved in different renal pathologic conditions. For these reasons, investigators and pharmaceutical companies are actively exploring novel strategies to antagonize or block these receptors with the goal of reducing extracellular ATP production or accelerating extracellular ATP clearance. Targeting extracellular ATP signaling, particularly through the P2X7 receptor, has considerable translational potential, given that novel P2X7-receptor inhibitors are already available for clinical use (e.g., CE224,535, AZD9056, and GSK1482160). This review summarizes the current evidence regarding the involvement of extracellular ATP and its P2 purinergic receptor-mediated signaling in physiologic and pathologic processes in the kidney; potential therapeutic options targeting extracellular ATP purinergic receptors are analyzed as well.
authors.affiliation: Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy;
authors.forename: Anna
authors.initials: A
authors.lastname: Solini
authors.affiliation: Division of Transplant Medicine, San Raffaele Hospital, Milan, Italy; and.
authors.forename: Vera
authors.initials: V
authors.lastname: Usuelli
authors.affiliation: Division of Transplant Medicine, San Raffaele Hospital, Milan, Italy; and Nephrology Division, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts paolo.fiorina@childrens.harvard.edu.
authors.forename: Paolo
authors.initials: P
authors.lastname: Fiorina
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism*; D000818:Animals; D045604:Extracellular Fluid / Q000378:metabolism*; D006801:Humans; D007668:Kidney / Q000378:metabolism; D007674:Kidney Diseases / Q000209:etiology / Q000378:metabolism*; D018048:Receptors, Purinergic P2 / Q000378:metabolism*
chemical_list: D018048:Receptors, Purinergic P2; D000255:Adenosine Triphosphate
keywords: diabetic nephropathy; extracellular ATP; kidney transplantation; purinergic receptors; type 1 diabetes; type 2 diabetes